These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 12423007

  • 21. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood.
    Hino Y, Ojanperä I, Rasanen I, Vuori E.
    Forensic Sci Int; 2003 Jan 28; 131(2-3):148-55. PubMed ID: 12590054
    [Abstract] [Full Text] [Related]

  • 22. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M, Haenseler E, Hoke C, Nichols J, Raab D, Domke I.
    Clin Lab; 2000 Jan 28; 46(1-2):49-52. PubMed ID: 10745981
    [Abstract] [Full Text] [Related]

  • 23. Urine levels of drugs for which Triage DOA screening was positive.
    Moriya F.
    Leg Med (Tokyo); 2009 Apr 28; 11 Suppl 1():S434-6. PubMed ID: 19261513
    [Abstract] [Full Text] [Related]

  • 24. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine.
    Fraser AD, Howell P.
    J Anal Toxicol; 1998 Apr 28; 22(1):50-4. PubMed ID: 9491969
    [Abstract] [Full Text] [Related]

  • 25. Urinary excretion of d-amphetamine following oral doses in humans: implications for urine drug testing.
    Poklis A, Still J, Slattum PW, Edinboro LF, Saady JJ, Costantino A.
    J Anal Toxicol; 1998 Oct 28; 22(6):481-6. PubMed ID: 9788523
    [Abstract] [Full Text] [Related]

  • 26. Screening for drugs of abuse with the Roche ONTRAK assays.
    Armbruster DA, Krolak JM.
    J Anal Toxicol; 1992 Oct 28; 16(3):172-5. PubMed ID: 1522711
    [Abstract] [Full Text] [Related]

  • 27. Improved screening for benzodiazepine metabolites in urine using the Triage Panel for Drugs of Abuse.
    Koch TR, Raglin RL, Kirk S, Bruni JF.
    J Anal Toxicol; 1994 Oct 28; 18(3):168-72. PubMed ID: 7914948
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of the DRI oxycodone immunoassay for the detection of oxycodone in urine.
    Backer RC, Monforte JR, Poklis A.
    J Anal Toxicol; 2005 Oct 28; 29(7):675-7. PubMed ID: 16419399
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of a colloidal metal immunoassay device for the detection of tricyclic antidepressants in urine.
    Poklis A, Edinboro LE, Lee JS, Crooks CR.
    J Toxicol Clin Toxicol; 1997 Oct 28; 35(1):77-82. PubMed ID: 9022656
    [Abstract] [Full Text] [Related]

  • 30. Performance of three point-of-care urinalysis test devices for drugs of abuse and therapeutic drugs applied in the emergency department.
    Attema-de Jonge ME, Peeters SY, Franssen EJ.
    J Emerg Med; 2012 Jun 28; 42(6):682-91. PubMed ID: 21911284
    [Abstract] [Full Text] [Related]

  • 31. Setting cutoff concentrations for immunoassay screening of postmortem blood.
    Collison IB, Spiehler VR, Guluzian S, Sedgwick PR.
    J Forensic Sci; 1998 Mar 28; 43(2):390-4. PubMed ID: 9544549
    [Abstract] [Full Text] [Related]

  • 32. Urine Drug Screening in the Era of Designer Benzodiazepines: Comparison of Three Immunoassay Platforms, LC-QTOF-MS and LC-MS-MS.
    Puzyrenko A, Wang D, Schneider R, Wallace G, Schreiber S, Brandt K, Gunsolus IL.
    J Anal Toxicol; 2022 Aug 13; 46(7):712-718. PubMed ID: 34557900
    [Abstract] [Full Text] [Related]

  • 33. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS.
    Beck O, Lin Z, Brodin K, Borg S, Hjemdahl P.
    J Anal Toxicol; 1997 Aug 13; 21(7):554-7. PubMed ID: 9399125
    [Abstract] [Full Text] [Related]

  • 34. Determination of five abused drugs in nitrite-adulterated urine by immunoassays and gas chromatography-mass spectrometry.
    Tsai SC, ElSohly MA, Dubrovsky T, Twarowska B, Towt J, Salamone SJ.
    J Anal Toxicol; 1998 Oct 13; 22(6):474-80. PubMed ID: 9788522
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of the NexScreen and DrugCheck Waive RT urine drug detection cups.
    Lin CN, Nelson GJ, McMillin GA.
    J Anal Toxicol; 2013 Oct 13; 37(1):30-6. PubMed ID: 23144203
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of two enzyme immunoassays for the detection of the cocaine metabolite benzoylecgonine in 1,398 urine specimens.
    Carney S, Wolf CE, Tarnai-Moak L, Poklis A.
    J Clin Lab Anal; 2012 May 13; 26(3):130-5. PubMed ID: 22628226
    [Abstract] [Full Text] [Related]

  • 37. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents.
    Pelletti G, Garagnani M, Rossi F, Roffi R, Barone R, Pelotti S.
    Forensic Sci Int; 2019 Jan 13; 294():27-33. PubMed ID: 30447484
    [Abstract] [Full Text] [Related]

  • 38. Papain: a novel urine adulterant.
    Burrows DL, Nicolaides A, Rice PJ, Dufforc M, Johnson DA, Ferslew KE.
    J Anal Toxicol; 2005 Jan 13; 29(5):275-95. PubMed ID: 16105251
    [Abstract] [Full Text] [Related]

  • 39. Accuracy of common drug screen tests.
    Schwartz JG, Zollars PR, Okorodudu AO, Carnahan JJ, Wallace JE, Briggs JE.
    Am J Emerg Med; 1991 Mar 13; 9(2):166-70. PubMed ID: 1994947
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of Triage screening for drugs of abuse in postmortem blood and urine samples.
    Moriya F, Hashimoto Y.
    Nihon Hoigaku Zasshi; 1997 Jun 13; 51(3):214-9. PubMed ID: 9301227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.